Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the Beneficial Effects of a Nasal Spray of Resveratrol in Children With Seasonal Allergic Rhinitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Children of both sexes, ranging in age from 4 to 17 years~* History of seasonal allergic rhinitis, mild, moderate or severe, defined according to the ARIA guidelines in 2010, documented by recurrent episodes in the previous year and confirmed by a positive skin test results~* Written informed consent from at least one parent or a legal representative~Exclusion Criteria:~* Lack of informed consent in writing by at least one parent or a legal representative~* Concomitant disorders, such as infection of the upper (sinusitis, etc..) or lower respiratory tract, nasal surgery in the last year, abnormalities of the respiratory tract, immune diseases~* Use of antihistamines, nasal or systemic corticosteroids, leukotriene modifiers, cromolyn sodium, in the last six weeks

- Gender: ALL
- Minimum Age: 4 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- Resveratrol nasal spray (Type: ACTIVE_COMPARATOR): 2 sprays per nostril 3 times a day for a period of two months
- Placebo (Type: PLACEBO_COMPARATOR): 2 sprays per nostril 3 times a day for a period of two months

Based on this trial design, predict the completion outcome and termination type (if applicable).